The abstract is read at the publisher; the summary is JClub's.
Machine learning is increasingly enabling predictive analyses of microbial pathogen evolution, including adaptation and drug resistance, using genomic data paired with geographic and risk-group metadata.
- Why it matters: The field faces scalability bottlenecks from heterogeneous, high-dimensional pathogen and epidemic datasets, limiting retrospective monitoring and constraining proactive forecasting.
- What they did: The review synthesizes ML applications that use genomic sequences with metadata (e.g., geographic locations, risk groups, sampling information) to predict adaptation and drug resistance, infer sources and hosts, flag high-risk lineages, and estimate phylodynamic and epidemiological parameters.
- The result: These methods are shifting molecular epidemiology toward a proactive, predictive framework for major global microbial threats, while also highlighting limitations in interpretability, uncertainty quantification, data-volume needs, and sensitivity to model misspecification.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.